Cleerly ISCHEMIA vs RX-1 Rhythm Express Remote Cardiac Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Cleerly ISCHEMIA focuses on the non-invasive detection of coronary artery ischemia and plaque characterization through AI-powered analysis of CCTA scans. Conversely, the RX-1 Rhythm Express Remote Cardiac Monitoring System is a wearable device designed for continuous ECG monitoring to detect arrhythmias. While both are FDA-cleared cardiology AI tools, they address different cardiac conditions and utilize distinct diagnostic modalities and data sources.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you need a non-invasive, AI-powered analysis of CCTA scans to precisely assess coronary artery disease, including plaque characteristics, stenosis severity, and the likelihood of vessel-level ischemia. This tool is ideal for guiding personalized diagnosis and treatment planning for patients with suspected or known coronary artery disease, providing detailed anatomical and functional insights without invasive procedures.

View Cleerly ISCHEMIA →

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose the RX-1 Rhythm Express Remote Cardiac Monitoring System if your patient requires continuous, long-term ECG monitoring to detect and characterize intermittent arrhythmias or other cardiac rhythm disturbances. This wearable patch is best suited for diagnosing conditions like palpitations, syncope, or atrial fibrillation, offering near real-time data transmission and superior noise suppression for accurate arrhythmia detection over extended periods.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA RX-1 Rhythm Express Remote Cardiac Monitoring System
Pricing Unknown Available
Deployment Web-based solution Cloud-based
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool B explicitly highlights features that enhance patient comfort and ease of use for its wearable device, such as compact design, water resistance, and extended battery life, which are crucial for adherence in remote monitoring. While Tool A focuses on physician interaction with comprehensive web-based reports, Tool B addresses usability for both patients and clinicians.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA offers a transformative clinical value by providing non-invasive functional (ischemia likelihood via FFR estimation) and anatomical (plaque characterization) insights from CCTA scans. This advanced diagnostic capability can significantly impact treatment pathways, potentially reducing the need for invasive procedures and guiding revascularization decisions.

Pricing & Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool B provides clear and flexible pricing models, including subscription, fee-for-service, and split-bill options, with detailed explanations of how costs are structured. This transparency allows healthcare providers to choose the model best suited for their practice. Tool A's pricing is less transparent, requiring direct contact for details.

Enterprise Readiness

Cleerly ISCHEMIA

Tool A explicitly mentions integration with PowerScribe via API and secure data transfer mechanisms (VPN or virtual appliance), indicating a mature approach to integrating within existing enterprise IT and clinical reporting workflows. Both are FDA-cleared, HIPAA compliant, and offer BAAs, but Tool A details more specific IT integration capabilities.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA's AI-enabled non-invasive fractional flow reserve (FFR) estimation and comprehensive coronary plaque characterization from CCTA scans represent a more disruptive innovation. It provides novel functional and anatomical insights that traditionally required more invasive procedures or less detailed analysis, potentially shifting diagnostic paradigms.

Support & Docs

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool B demonstrates superior support and documentation by offering comprehensive 24/7/365 phone and email support for both patients and providers, along with a range of detailed user guides and the option for onsite training. Tool A mentions client support but without the same level of detail regarding availability or specific resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA RX-1 Rhythm Express Remote Cardiac Monitoring System
Name Cleerly ISCHEMIA RX-1 Rhythm Express Remote Cardiac Monitoring System
Company Cleerly VivaQuant
Description Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. The RX-1 Rhythm Express Remote Cardiac Monitoring System by VivaQuant is an FDA-cleared, patch-style wearable device offering continuous ECG monitoring in MCT, Event, and Holter modes. It utilizes proprietary MDSPu2122 technology for superior noise suppression and accurate arrhythmia detection, providing near real-time data transmission to a cloud platform for physician review.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology
Key Features AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API Proprietary Multi-Domain Signal Processing (MDSPu2122) technology for noise suppression, AI-enabled advanced signal processing for arrhythmia detection, Continuous 2-channel ECG monitoring, Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH) modes, Extended battery life (up to 5 days on a single charge), Water-resistant (IP64) and compact design, Built-in cellular connectivity for near real-time data transmission, Automated arrhythmia detection and patient-triggered event recording

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and RX-1 Rhythm Express Remote Cardiac Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is an AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. The RX-1 Rhythm Express Remote Cardiac Monitoring System is a wearable device for continuous ECG monitoring in MCT, Event, and Holter modes, focusing on accurate arrhythmia detection and providing near real-time data for physician review.
Cleerly ISCHEMIA uses AI-enabled CCTA analysis to estimate non-invasive fractional flow reserve (FFR), characterize coronary plaque, and assess stenosis severity. The RX-1 Rhythm Express system utilizes proprietary Multi-Domain Signal Processing (MDSPu2122) technology for noise suppression and AI-enabled advanced signal processing for arrhythmia detection from continuous ECG data.
Cleerly ISCHEMIA provides comprehensive interactive web-based reports that include vessel-level ischemia likelihood, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment. The RX-1 Rhythm Express system delivers continuous 2-channel ECG monitoring data with automated arrhythmia detection and patient-triggered event recording to a cloud platform for physician review.
Cleerly ISCHEMIA is designed for use in Cardiology and Radiology specialties. The RX-1 Rhythm Express Remote Cardiac Monitoring System is primarily targeted at Cardiology.
Cleerly ISCHEMIA offers comprehensive interactive web-based reports and integrates with PowerScribe via API for streamlined reporting. The RX-1 Rhythm Express transmits near real-time data to a cloud-based platform for data management and review, and can integrate with existing Electronic Health Record (EHR) systems through a third-party integrator.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.